The need to develop β-lactamase inhibitors against class C cephalosporinases of Gram-negative pathogens represents an urgent clinical priority. To respond to this challenge, five boronic acid derivatives including a new cefoperazone analog were synthesized and tested against the class C cephalosporinase of Acinetobacter baumannii (Acinetobacter-Derived Cephalosporinase, ADC). The commercially available carbapenems antibiotics were also assayed. In the boronic acid series, a chiral cephalothin analog with a meta-carboxyphenyl moiety corresponding to the C 3 /C 4 carboxylate of β-lactams showed the lowest K i (11 ± 1 nM). In antimicrobial susceptibility tests, this cephalothin analog lowered the ceftazidime and cefotaxime minimum inhibitory concentrations (MICs) of Escherichia coli DH10B cells carrying bla ADC from 16 → 4 μg/ml, and 8 → 1 μg/ml, respectively. On the other hand, each carbapenem exhibited a K i < 20 μM, and timed electrospray ionization mass spectrometry (ESI-MS) demonstrated the formation of adducts corresponding to acyl-enzyme intermediates with both intact carbapenem and carbapenem lacking the C 6 hydroxyethyl group. To better understand the interactions between the β-lactamase and the inhibitors, we † This work was supported in part by the Department of Veterans Affairs Merit Review Program and National Institutes of Health (NIH) Grant 1R01 A1063517-01. RAB is also supported by the Veterans Integrated Service Network 10 Geriatric Research, Education, and Clinical Center. SMD was supported in part by NIH Grant T32 GM07250 and the CWRU Medical Scientist Training Program. MB was supported by the Wyeth Fellowship in Antimicrobial Resistance at CWRU. FP, EC, and CO gratefully thank Fondazione Cassa di Risparmio di Modena for financial support. Supporting Information Available. ADC β-lactamase model validation reports and multiple sequence protein alignment of crystal structure coordinates for E. cloacae P99 (PDB entry 1XX2), E. coli AmpC (PDB entry 2BLS), and the ADC model are available free of charge via the Internet at http://pubs.acs.org.
NIH Public Access
Author ManuscriptBiochemistry. Author manuscript; available in PMC 2011 January 19.
Published in final edited form as:Biochemistry. 2010 January 19; 49(2): 329-340. doi:10.1021/bi9015988.
NIH-PA Author ManuscriptNIH-PA Author Manuscript NIH-PA Author Manuscript constructed models of ADC as an acyl-enzyme with: i) the meta-carboxyphenyl cephalothin analog; and ii) the carbapenems imipenem and meropenem. Our first model suggests that this chiral cephalothin analog adopts a novel conformation in the β-lactamase active site. Further, the addition of the substituent mimicking the cephalosporin dihydrothiazine ring may significantly improve affinity for the ADC β-lactamase. In contrast, the ADC: carbapenem models offer a novel role for the R 2 side group, and also suggest that elimination of the C6 hydroxyethyl group by retroaldolic reaction leads to a significant conformational change of the acyl-enzyme. Lessons from the diverse mechanisms an...